Nikiforov, D. M.
Povarnina, P. Yu.
Gudasheva, T. A.
Nadorova, A. V.
Kolik, L. G.
Valdman, E. A.
Vakhitova, Yu. V.
Seredenin, S. B.
Article History
Received: 10 September 2024
Revised: 25 September 2024
Accepted: 30 September 2024
First Online: 22 January 2025
ETHICS APPROVAL AND CONSENT TO PARTICIPATE
: The experiments with animals were carried out in accordance with the Decision of the Council of the Eurasian Economic Commission of November 3, 2016 no. 81 “On approval of the Rules of Good Laboratory Practice of the Eurasian Economic Union in the Sphere of Circulation of Medicines,” interstate standards of the series “Guidelines for the Care and Maintenance of Laboratory Animals” GOST 33215-2014 and GOST 33216-2014 (Appendix A to the European Convention for the Protection of Vertebrate Animals used in Experimental and Other Scientific Purposes (ETS N 123)). The experiments were approved by the Biomedical Ethics Commission of the Federal Research Center of Original and Promising Biomedical and Pharmaceutical Technologies (protocol no. 5 of April 19, 2022).
: The authors of this work declare that they have no conflicts of interest.